Some seemingly simple sequences of multiplication and addition grow so quickly that they question the very foundations of ...

Theoretical ideas have a real-life impact,” said Michael Oser Rabin in a 2009 interview, 1 and he spent nearly seven decades ...

SPDR S&P Biotech ETF (XBI) holds 150+ equal-weight positions and is up 46% over the past year, but faces near-term headwinds from FDA staffing cuts that could slow the regulatory approval pipeline ...

Recursive self improvement is the key to solving intelligence. Human intelligence is built on our ability to characterize the world in words, images, numbers and sounds (what I called WINS work in my ...

VUB's Data Analytics Lab has published new results showing that it is possible to develop original mathematical proofs using commercial language models. In a paper posted to the arXiv preprint server, ...

These properties make PIRTM suitable as the safety-critical inner loop for AI inference engines, certified control systems, and any computation that must be auditable after the fact. Classical ...

Abstract: Since many mathematical morphology operations are recursive transforms of dilation and erosion, this paper proposes fast recursive transforms to reduce computational complexity. The basic ...

Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...